Efficacy and safety of selenium nanoparticles administered intraperitoneally for the prevention of growth of cancer cells in the peritoneal cavity

Free Radical Biology and Medicine

Volumn 72, Issue , 2014, Pages 1-10

  Wang, Xin ^a   Sun, Kang ^a   Tan, Yanping ^a   Wu, Shanshan ^a   Zhang, Jinsong ^a  

^a ANHUI AGRICULTURAL UNIVERSITY   (China)

Author keywords

Free radicals; Intraperitoneal administration; Nanoparticles; Peritoneal carcinomatosis; Selective drug distribution; Selenium

Indexed keywords

GLUTATHIONE; REACTIVE OXYGEN METABOLITE; SELENIUM; ANTINEOPLASTIC AGENT; NANOPARTICLE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER INHIBITION; CANCER PREVENTION; CANCER RISK; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFICACY; DRUG SAFETY; LIVER CELL CARCINOMA; MALE; MOUSE; NONHUMAN; PERITONEAL CAVITY; PERITONEUM CANCER; PRIORITY JOURNAL; TARGET CELL; ANIMAL; CARCINOMA; DRUG EFFECTS; PERITONEAL NEOPLASMS; SECONDARY; TUMOR SEEDING;

ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOMA; CELL PROLIFERATION; MALE; MICE; NANOPARTICLES; NEOPLASM SEEDING; PERITONEAL NEOPLASMS; SELENIUM;

EID: 84899516671     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2014.04.003     Document Type: Article

References (52)

1. A. Nissan, A. Stojadinovic, A. Garofalo, J. Esquivel, and P. Piso Evidence-based medicine in the treatment of peritoneal carcinomatosis: past, present, and future J. Surg. Oncol. 100 2009 335 344
2. C.H. Lin, H.F. Hsieh, J.C. Yu, T.W. Chen, C.Y. Yu, and C.B. Hsieh Peritoneal lavage with distilled water during liver resection in patients with spontaneously ruptured hepatocellular carcinomas J. Surg. Oncol. 94 2006 255 256
3. T. Sonoda, T. Kanematsu, K. Takenaka, and K. Sugimachi Ruptured hepatocellular carcinoma evokes risk of implanted metastases J. Surg. Oncol. 41 1989 183 186
4. N. Hayes, J. Wayman, V. Wadehra, D.J. Scott, S.A. Raimes, and S.M. Griffin Peritoneal cytology in the surgical evaluation of gastric carcinoma Br. J. Cancer 79 1999 520 524
5. E.L. Huguet, and N.J. Keeling Distilled water peritoneal lavage after colorectal cancer surgery Dis. Colon Rectum 47 2004 2114 2119
6. C.W. Helm Ports and complications for intraperitoneal chemotherapy delivery BJOG 119 2012 150 159
7. Z. Lu, J. Wang, M.G. Wientjes, and J.L. Au Intraperitoneal therapy for peritoneal cancer Future Oncol 6 2010 1625 1641
8. C. Hasovits, and S. Clarke Pharmacokinetics and pharmacodynamics of intraperitoneal cancer chemotherapeutics Clin. Pharmacokinet. 51 2012 203 224
9. A.G. Zeimet, D. Reimer, A.C. Radl, A. Reinthaller, C. Schauer, E. Petru, N. Concin, S. Braun, and C. Marth Pros and cons of intraperitoneal chemotherapy in the treatment of epithelial ovarian cancer Anticancer Res. 29 2009 2803 2808
10. S.H. Noh, C.H. Yoo, H.C. Chung, J.K. Roh, D.W. Shin, and J.S. Min Early postoperative intraperitoneal chemotherapy with mitomycin C, 5-fluorouracil and cisplatin for advanced gastric cancer Oncology 60 2001 24 30
11. E.S. Arnér Focus on mammalian thioredoxin reductases - important selenoproteins with versatile functions Biochim. Biophys. Acta 495-526 1790 2009
12. E. Lubos, J. Loscalzo, and D.E. Handy Glutathione peroxidase-1 in health and disease: from molecular mechanisms to therapeutic opportunities Antioxid. Redox Signaling 15 2011 1957 1997
13. J.E. Spallholz On the nature of selenium toxicity and carcinostatic activity Free Radic. Biol. Med. 17 1994 45 64
14. Y. Seko, and N. Imura Active oxygen generation as a possible mechanism of selenium toxicity Biomed. Environ. Sci. 10 1997 333 339
15. C. Ip Lessons from basic research in selenium and cancer prevention J. Nutr. 128 1998 1845 1854
16. X. Jia, N. Li, and J. Chen A subchronic toxicity study of elemental Nano-Se in Sprague-Dawley rats Life Sci. 76 2005 1989 2003
17. H. Steinbrenner, B. Speckmann, and H. Sies Toward understanding success and failures in the use of selenium for cancer prevention Antioxid. Redox Signaling 19 2013 181 191
18. G.A. Greeder, and J.A. Milner Factors influencing the inhibitory effect of selenium on mice inoculated with Ehrlich ascites tumor cells Science 209 1980 825 827
19. J.A. Milner, and C.Y. Hsu Inhibitory effects of selenium on the growth of L1210 leukemic cells Cancer Res. 41 1981 1652 1656
20. J.S. Zhang, X.Y. Gao, L.D. Zhang, and Y.P. Bao Biological effects of a nano red elemental selenium Biofactors 15 2001 27 38
21. A.D. Smith, and O.A. Levander High-throughput 96-well microplate assays for determining specific activities of glutathione peroxidase and thioredoxin reductase Methods Enzymol. 347 2002 113 121
22. I. Calberg, and B. Mannervik Glutathione reductase Methods Enzymol. 113 1985 484 490
23. W.H. Habig, M.J. Pabst, and W.B. Jakoby Glutathione S-transferases: the first enzymatic step in mercapturic acid formation J. Biol. Chem. 249 1974 7130 7139
24. O.E. Olson, I.S. Palmer, and E.E. Cary Modification of the official fluorometric method for selenium in plants J. Assoc. Off. Anal. Chem. 58 1975 117 121
25. A. Holmgren, and M. Björnstedt Thioredoxin and thioredoxin reductase Methods Enzymol. 252 1995 199 208
26. X. Wang, J. Zhang, and T. Xu Cyclophosphamide-evoked heart failure involves pronounced co-suppression of cytoplasmic thioredoxin reductase activity and non-protein free thiol level Eur. J. Heart Fail. 11 2009 154 162
27. L.M. Landrum, M.A. Gold, K.N. Moore, T.K. Myers, D.S. McMeekin, and J.L. Walker Intraperitoneal chemotherapy for patients with advanced epithelial ovarian cancer: a review of complications and completion rates Gynecol. Oncol. 108 2008 342 347
28. S. Cao, F.A. Durrani, and Y.M. Rustum Selective modulation of the therapeutic efficacy of anticancer drugs by selenium containing compounds against human tumor xenografts Clin. Cancer Res. 10 2004 2561 2569
29. J. Zhang, X. Wang, and T. Xu Elemental selenium at nano size (Nano-Se) as a potential chemopreventive agent with reduced risk of selenium toxicity: comparison with Se-methylselenocysteine in mice Toxicol. Sci. 101 2008 22 31
30. L. Yan, and J.E. Spallholz Generation of reactive oxygen species from the reaction of selenium compounds with thiols and mammary tumor cells Biochem. Pharmacol. 45 1993 429 437
31. F. Ali-Osman, D.E. Stein, and A. Renwick Glutathione content and glutathione-S-transferase expression in 1,3-bis(2-chloroethyl)-1-nitrosourea- resistant human malignant astrocytoma cell lines Cancer Res. 50 1990 6976 6980
32. S.C. Barranco, C.M. Townsend Jr, B. Weintraub, E.G. Beasley, K.K. MacLean, J. Shaeffer, N.H. Liu, and K. Schellenberg Changes in glutathione content and resistance to anticancer agents in human stomach cancer cells induced by treatments with melphalan in vitro Cancer Res. 50 1990 3614 3618
33. H. Wang, J. Zhang, and H. Yu Elemental selenium at nano size possesses lower toxicity without compromising the fundamental effect on selenoenzymes: comparison with selenomethionine in mice Free Radic. Biol. Med. 42 2007 1524 1533
34. J. Zhang, H. Wang, X. Yan, and L. Zhang Comparison of short-term toxicity between Nano-Se and selenite in mice Life Sci. 76 2005 1099 1109
35. J. Zhang, H. Wang, D. Peng, and E.W. Taylor Further insight into the impact of sodium selenite on selenoenzymes: high-dose selenite enhances hepatic thioredoxin reductase 1 activity as a consequence of liver injury Toxicol. Lett. 176 2008 223 229
36. L. Kong, Q. Yuan, H. Zhu, Y. Li, Q. Guo, Q. Wang, X. Bi, and X. Gao The suppression of prostate LNCaP cancer cells growth by selenium nanoparticles through Akt/Mdm2/AR controlled apoptosis Biomaterials 32 2011 6515 6522
37. L. De Smet, W. Ceelen, J.P. Remon, and C. Vervaet Optimization of drug delivery systems for intraperitoneal therapy to extend the residence time of the chemotherapeutic agent ScientificWorldJournal 2013 2013 720858
38. A. Holmgren Selenite in cancer therapy: a commentary on Selenite induces apoptosis in sarcomatoid malignant mesothelioma cells through oxidative stress Free Radic. Biol. Med. 41 2006 862 865
39. L.C. Clark, G.F. Combs Jr, B.W. Turnbull, E.H. Slate, D.K. Chalker, J. Chow, L.S. Davis, R.A. Glover, G.F. Graham, E.G. Gross, A. Krongrad, J.L. Lesher Jr, H.K. Park, B.B. Sanders Jr, C.L. Smith, and J.R. Taylor Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin: a randomized controlled trial Nutritional Prevention of Cancer Study Group. JAMA 276 1996 1957 1963
40. S.M. Lippman, E.A. Klein, P.J. Goodman, M.S. Lucia, I.M. Thompson, L.G. Ford, H.L. Parnes, L.M. Minasian, J.M. Gaziano, J.A. Hartline, J.K. Parsons, J.D. Bearden 3rd, E.D. Crawford, G.E. Goodman, J. Claudio, E. Winquist, E.D. Cook, D.D. Karp, P. Walther, M.M. Lieber, A.R. Kristal, A.K. Darke, K.B. Arnold, P.A. Ganz, R.M. Santella, D. Albanes, P.R. Taylor, J.L. Probstfield, T.J. Jagpal, J.J. Crowley, F.L. Meyskens Jr, L.H. Baker, and C.A. Coltman Jr. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT) JAMA 301 2009 39 51
41. M.S. Geybels, B.A. Verhage, F.J. van Schooten, R.A. Goldbohm, and P.A. van den Brandt Advanced prostate cancer risk in relation to toenail selenium levels J. Natl. Cancer Inst. 105 2013 1394 1401
42. G.V. Kryukov, S. Castellano, S.V. Novoselov, A.V. Lobanov, O. Zehtab, R. Guigó, and V.N. Gladyshev Characterization of mammalian selenoproteomes Science 300 2003 1439 1443
43. C.M. Rebsch, F.J. Penna 3rd, and P.R. Copeland Selenoprotein expression is regulated at multiple levels in prostate cells Cell Res. 16 2006 940 948
44. M. Weiller, M. Latta, M. Kresse, R. Lucas, and A. Wendel Toxicity of nutritionally available selenium compounds in primary and transformed hepatocytes Toxicology 201 2004 21 30
45. J. Zhang, D. Peng, H. Lu, and Q. Liu Attenuating the toxicity of cisplatin by using selenosulfate with reduced risk of selenium toxicity as compared with selenite Toxicol. Appl. Pharmacol. 226 2008 251 259
46. J. Li, K. Sun, L. Ni, X. Wang, D. Wang, and J. Zhang Sodium selenosulfate at an innocuous dose markedly prevents cisplatin-induced gastrointestinal toxicity Toxicol. Appl. Pharmacol. 258 2012 376 383
47. Y.R. Seo, M.R. Kelley, and M.L. Smith Selenomethionine regulation of p53 by a ref1-dependent redox mechanism Proc. Natl. Acad. Sci. USA 99 2002 14548 14553
48. J.L. Fischer, E.M. Mihelc, K.E. Pollok, and M.L. Smith Chemotherapeutic selectivity conferred by selenium: a role for p53-dependent DNA repair Mol. Cancer Ther. 6 2007 355 361
49. M.L. Smith, J.K. Lancia, T.I. Mercer, and C. Ip Selenium compounds regulate p53 by common and distinctive mechanisms Anticancer Res. 24 2004 1401 1408
50. C.L. Liu, S.T. Fan, C.M. Lo, I.O. Ng, R.T. Poon, and J. Wong Intraoperative iatrogenic rupture of hepatocellular carcinoma World J. Surg. 26 2002 348 352
51. C.L. Liu, S.T. Fan, C.M. Lo, W.K. Tso, R.T. Poon, C.M. Lam, and J. Wong Management of spontaneous rupture of hepatocellular carcinoma: single-center experience J. Clin. Oncol. 19 2001 3725 3732
52. G.B. Ong, E.P. Chu, F.Y. Yu, and T.C. Lee Spontaneous rupture of hepatocellular carcinoma Br. J. Surg. 52 1965 123 129